Interactions of Body Weight Loss with Lipophilic Toxin Storage: Commentary
- PMID: 38244860
- PMCID: PMC10942849
- DOI: 10.1016/j.tjnut.2024.01.018
Interactions of Body Weight Loss with Lipophilic Toxin Storage: Commentary
Abstract
A high incidence of obesity and surplus body fat has been observed in wealthy countries for many decades. It is generally recognized that these excesses contribute to serious disease states, including type 2 diabetes and cardiovascular diseases. On the other hand, the adipose tissue stores relatively safely many environmental lipophilic toxins. However, rapid weight loss mobilizes these toxins to the blood to be exposed to vital organs, such as the brain, lungs, and others. With the introduction of potent diabetic drugs causing rapid weight reduction, the question of mobilization of lipophilic toxins to the blood should be considered. In this commentary, we raised this mobilization of adipose tissue toxins to the readers. Also, we discussed how these toxins may be eliminated from the body through the use of nondigestible fat, such as olestra or lipase inhibitors, such as Xenical.
Keywords: blood lipophilic toxins; enterohepatic circulation; food intake; lipoproteins; red blood cell.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
[Pharmacological therapy of obesity].G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. G Ital Cardiol (Rome). 2008. PMID: 18773755 Italian.
-
Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene.Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G292-9. doi: 10.1152/ajpgi.00285.2004. Epub 2004 Oct 28. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15513954
-
Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.Diabetes Obes Metab. 2009 Apr;11(4):361-71. doi: 10.1111/j.1463-1326.2008.00970.x. Epub 2009 Jan 22. Diabetes Obes Metab. 2009. PMID: 19207292
-
New aspects in the management of obesity: operation and the impact of lipase inhibitors.Curr Opin Lipidol. 1999 Feb;10(1):3-7. doi: 10.1097/00041433-199902000-00002. Curr Opin Lipidol. 1999. PMID: 10095983 Review.
-
New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.Diabetes Metab. 2002 Dec;28(6 Pt 1):437-45. Diabetes Metab. 2002. PMID: 12522323 Review.
References
-
- Ploteau S., Antignac J.P., Volteau C., Marchand P., Vénisseau A., Vacher V., et al. Distribution of persistent organic pollutants in serum, omental, and parietal adipose tissue of French women with deep infiltrating endometriosis and circulating versus stored ratio as new marker of exposure. Environ. Int. 2016;97:125–136. - PubMed
-
- Malarvannan G., Van Hoorenbeeck K., Deguchtenaere A., Verhulst S.L., Dirinck E., Van Gaal L., et al. Dynamics of persistent organic pollutants in obese adolescents during weight loss. Environ. Int. 2018;110:80–87. - PubMed
-
- Cheikh Rouhou M., Karelis A.D., St-Pierre D.H., Lamontagne L. Adverse effects of weight loss: are persistent organic pollutants a potential culprit? Diabetes Metab. 2016;42:215–223. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical